Clicky

Silex Systems Limited(RW4)

Description: Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. The company operates in three segments: Silex Systems, Translucent, and Silex USA. The company sells its cREO technology; and develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.


Keywords: Cancer Uranium Cancer Therapies Uranium Mining Isotope Separation Enriched Uranium Separation Of Isotopes By Laser Excitation Silex Laser Enrichment Technology Laser Isotope Separation C Reo Technology Nuclear Proliferation Technology Commercialization

Home Page: www.silex.com.au

Building 64
Sydney, NSW 2234
Australia
Phone: 61 2 9704 8888


Officers

Name Title
Dr. Michael P. Goldsworthy B.Sc., BSc (Hons), FAIP, GAICD, M.Sc., MSc, Ph.D. CEO, MD & Executive Director
Ms. Julie E Russell B.Bus., C.A., CA, GAICD, M.B.A. CFO & Company Secretary
Dr. Geordie Graetz M.A., Ph.D. Chief Commercial Officer

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 833.3333
Trailing PE: 0
Price-to-Book MRQ: 10.2143
Price-to-Sales TTM: 78.6712
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks